Cardinal Health Inc
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Cardinal Health Inc (CAH). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | – | – | $164.60B 90.7% | $188.81B 92.1% · +14.7% | $210.02B 92.6% · +11.2% | $204.64B 91.9% · -2.6% |
| GMPD | – | – | $13.28B 7.3% | $12.22B 6.0% · -8.0% | $12.38B 5.5% · +1.3% | $12.64B 5.7% · +2.1% |
| Other Operating Segment | – | – | $3.52B 1.9% | $4.02B 2.0% · +14.3% | $4.51B 2.0% · +12.2% | $5.38B 2.4% · +19.3% |
| Pharmaceutical | $137.50B 89.9% | $145.80B 89.7% · +6.0% | – | – | – | – |
| Medical | $15.44B 10.1% | $16.69B 10.3% · +8.0% | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Pharmaceutical and Specialty Solutions | – | – | $1.64B 1.0% | $1.88B 1.0% | $2.02B 1.0% | $2.26B 1.1% |
| GMPD | – | – | -$64.0M -0.5% | -$147.0M -1.2% | $92.0M 0.7% | $135.0M 1.1% |
| Other Operating Segment | – | – | $390.0M 11.1% | $396.0M 9.8% | $423.0M 9.4% | $516.0M 9.6% |
| Pharmaceutical | $1.75B 1.3% | $1.68B 1.2% | – | – | – | – |
| Medical | $663.0M 4.3% | $577.0M 3.5% | – | – | – | – |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| United States | $148.71B 97.2% | $157.76B 97.1% · +6.1% | $179.47B 98.9% · +13.8% | $203.44B 99.2% · +13.4% | $225.23B 99.3% · +10.7% | $220.99B 99.3% · -1.9% |
| International | $4.23B 2.8% | $4.73B 2.9% · +11.7% | $1.92B 1.1% · -59.3% | $1.62B 0.8% · -15.9% | $1.68B 0.7% · +4.0% | $1.67B 0.7% · -0.7% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.